RetinaLyze Nordic ApS: Financial statements 2022
CVR: 37219444
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
RetinaLyze Nordic ApS (CVR 37219444) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 252,809 and a net result of DKK 191,925 compared with DKK 104,829 the year before. That is an increase of 80.7% compared with the year before. Equity in the 2022 report amounted to DKK 410,257. The solvency ratio was 78.4%.
- Gross Profit
- DKK 252,809
- Profit/Loss
- DKK 191,925
- Equity
- DKK 410,257
- Total Assets
- DKK 523,118
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 253K | 192K | 410K | - |
| 2021 | - | 140K | 105K | 218K | - |
| 2020 | - | 53K | 33K | 114K | - |
| 2019 | - | 107K | 79K | 80K | - |
| 2018 | - | 22K | 10K | 2K | - |
Official annual report
Keep an eye on RetinaLyze Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
RetinaLyze Nordic ApS has published its annual report for 2021. Gross profit came to DKK 139,937, and the net result was DKK 104,829.
About RetinaLyze Nordic ApS
RetinaLyze Nordic ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company is registered under the industry Ikke-specialiseret engroshandel. The company was previously named UniVision ApS. The management consists of Peter Jørgensen. The company is owned by MountVision ApS. In 2025, the company reported a gross profit of DKK 213,373 and a net result of DKK 158,437 compared with DKK 145,520 the year before. Equity in the 2025 report amounted to DKK 218,437.